Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin; a case report

BACKGROUND: Genvoya® (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is a recent single regimen for the treatment of Human Immunodeficiency Virus (HIV). However, because of its complexity, it is difficult to predict drug interactions, especially when associated with HMG-CoA reductase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Godinho, Rita, Bugnon, Serge, Gracin, Terezija, Tataw, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390564/
https://www.ncbi.nlm.nih.gov/pubmed/30808332
http://dx.doi.org/10.1186/s12882-019-1257-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390564/
https://www.ncbi.nlm.nih.gov/pubmed/30808332
http://dx.doi.org/10.1186/s12882-019-1257-6

Ejemplares similares